Battery-operated skin patch offers new option for migraine sufferers

Battery-operated skin patch offers new option for migraine sufferers
FDA recently approved Zecuity patch to treat the painful headaches.

(HealthDay)—The first skin patch approved to treat migraines offers patients an alternative to pills, nasal sprays and injections, the U.S. Food and Drug Administration says.

The agency approved the Zecuity patch in January 2013 as a treatment for migraines after they begin. The patch contains sumatriptan (brand name Imitrex), a widely prescribed drug for treating migraines, and wraps around the arm or thigh like an ACE bandage.

"Although consumers are familiar with using a patch for, say, , this is the first patch the FDA has approved to treat migraines," Dr. Eric Bastings, a neurologist and deputy director of the FDA's Division of Neurology, said in an agency news release.

The battery-powered Zecuity patch uses an electrical current to move the drug through the skin over the course of four hours. A computer chip regulates the charge to ensure the patients receive the proper dosage.

There are some drawbacks, however.

The patch, which is about 8 inches long and 4 inches wide, is large enough that it can show when worn under short-sleeved shirts or shorts, and requires some privacy to put it on.

"For many people, popping a pill is a lot more immediate and simple," Bastings said.

But he noted that other methods of taking migraine medications also have downsides. The can leave an unpleasant aftertaste and some people are uncomfortable with giving themselves injections.

"Many experience debilitating pain—sometimes so acute that they can't swallow a pill," Bastings added.

In a clinical study, about 25 percent of patients complained of a painful sensation at the patch application site, while others were unhappy with the skin reddening that most patients developed after using the patch.

More than 30 million Americans suffer from migraines, according to the FDA.

More information: The U.S. National Institute of Neurological Disorders and Stroke has more about migraines.

Related Stories

FDA approves first skin patch to combat migraines

Jan 21, 2013

(HealthDay News) —A skin patch for the treatment of migraines, and the intense waves of nausea that often accompany these debilitating headaches, has been approved by the U.S. Food and Drug Administration.

New warning OK'd for birth control patch

Jan 21, 2008

The U.S. Food and Drug Administration has approved a warning for the Ortho Evra Contraceptive Transdermal Patch label concerning the risk of blood clots.

Recommended for you

WHO revises Ebola toll

37 minutes ago

The World Health Organization Friday revised its figures showing more people killed by the deadly Ebola virus, but the number of cases of the disease was slightly lower.

Routines most vital in avoiding Ebola infection: WHO

18 hours ago

Meticulously following stringent routines when putting on and removing protective equipment is more important than the kind of gear health care workers use to ward off Ebola infection, the World Health Organization said Friday.

A look at latest Ebola developments

19 hours ago

No African countries are on the United Nations list of contributors to fight Ebola. With few exceptions, African governments and institutions are offering only marginal support as the continent faces its ...

Liberia opens one of largest Ebola treatment centers

19 hours ago

Remembering those who have died in the world's deadliest Ebola outbreak, Liberia's president opened one of the country's largest Ebola treatment centers in Monrovia on Friday amid hopes that the disease is ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.